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Background: Bone marrow (BM) is a major hematopoietic organ that can harbour a variety of vector-borne pathogens;
however, knowledge of BM pathological changes in dogs infected with vector-borne pathogens is limited. Thus, the aim
of the present study was to assess the pathological changes in canine BM associated with natural infections by four
vector-borne pathogens, as well as to determine the relationships between such changes and abnormalities of
the peripheral blood.
Methods: Cytological disorders and pathological changes of the BM of 83 dogs naturally-infected with one or
more of four vector-borne pathogens (i.e., Anaplasma platys, Leishmania infantum, Babesia vogeli and Hepatozoon
canis) were evaluated and compared with the corresponding hematological findings.
Results: Dysgranulopoiesis and dysmegakaryocytopoiesis were the most frequently observed BM abnormalities in
infected dogs. Erythroid suppression, and lymphocytic, monocytic and macrophage hyperplasia were also observed.
Interestingly, associations between suppression and hyperplasia of specific cell lines in the marrow and corresponding
changes in numbers of circulating peripheral blood cells were not observed.
Conclusions: Infections with one or more of the vector-borne pathogens examined in this study should be considered
as differential diagnoses for secondary dysmyelopoiesis.
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The bone marrow (BM) is the major hematopoietic organ
and a primary lymphoid tissue. In dogs, the BM can become
infected with pathogens such as Leishmania infantum [1],
Hepatozoon canis [2] and Anaplasma platys [3]; therefore,
the BM is considered a sensitive tissue for the detection of
these pathogens [4,5]. Since the above-mentioned pathogens
are transmitted by arthropod vectors, they are commonly
referred to as canine vector-borne diseases (CVBDs);
CVBDs are widely distributed and highly prevalent through-
out much of the world, including the southern Mediterra-
nean region [6]. Furthermore, multiple canine vector-borne
pathogens can simultaneously infect the same host, thereby
causing co-infections, which may exacerbate disease severity* Correspondence: donato.decaprariis@uniba.it
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unless otherwise stated.and alter clinical and pathological scenarios associated with
single infections, thus complicating diagnosis, treatment and
prognosis in co-infected dogs [7]. The presence of vector-
borne pathogens in the BM may induce substantial alter-
ations in erythrocyte, granulocyte, monocyte, lymphocyte
and thrombocyte numbers and/or function. Despite the high
prevalence of CVBDs [6], only a few studies have investi-
gated BM alterations in dogs infected solely by L. infantum
[8-10] or by Ehrlichia canis [11]. In these studies, BM alter-
ations associated with infections by L. infantum included
emperipolesis, megakaryocytes dysplasia and BM aplasia,
whereas myelosuppression was induced by E. canis infec-
tion. However, thus far, knowledge of the BM alterations as-
sociated with infections by other CVBDs, including H. canis
and B. vogeli, as well as with co-infections by multiple
CVBD pathogens, is lacking. Therefore, the aim of the
present study was to provide insights into the BM changes
that occur in dogs naturally-infected by one or more of fourentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and L. infantum) and to determine the relationships be-




Animals included in this study were handled according
to the principles of Good Clinical Practice (VICH GL9
GCP, 2000). The study design and the experimental pro-
cedures were approved and authorized by the Italian
Ministry of Health (authorization number DGSA nu.
0001997; 04/02/2011; cf. [12,13]).
Animals
Samples from 83 crossbred dogs, 47 males and 36 females,
of different age (ranging from 3 months to 6 years of age),
unequivocally diagnosed with one or more CVBD (based
on serological, cytological and molecular assays performed
on a variety of tissues) were selected from a collection of
samples examined in previously published studies [12,13].
Dogs were selected based on the following criteria: (1)
positivity to one or more vector-borne pathogens docu-
mented by cytology and molecular assays and (2) the suit-
ability of blood and BM smears for subsequent cytological
evaluation. BM smears with evidence of blood contamin-
ation (i.e. high number of mature neutrophils, numerous
platelet aggregates and few marrow cells) were excluded
from the study. The selected cases were divided into
4 groups according to the detected pathogen(s) (which in-
cluded A. platys, B. vogeli, H. canis, and L. infantum,
Table 1). No dog included in this study was E. canis sero-
reactive or PCR positive.
Sample collection and laboratory procedures
Blood samples were collected from the brachial or jugu-
lar vein of each dog and a complete blood count (CBC)
was performed using an automatic cell counter (Abbott
Cell-Dyn 3700, Laboratorio di Analisi Cliniche Veterinarie,Table 1 Group classification of 83 dogs according to the
infecting vector-borne pathogens
Group CVBD N° of dogs
Ap Anaplasma platys 10
Hc Hepatozoon canis 33
Li Leishmania infantum 13
Co-i Co-infections H. canis - L. infantum 12
H. canis - A. platys 10
H. canis – Babesia vogeli 2
A. platys -Babesia vogeli 1
H. canis - A. platys - Babesia vogeli 2
Tot 83ACV Triggiano, Bari). Blood and buffy coat smears were
prepared and stained with the MGG Quick Stain (Bio
Optica Spa, Milan, Italy). Bone marrow aspirates were
obtained under local anesthesia with lidocaine hydro-
chloride 2%, (Lidocaina 20, Pfizer Olot, S.L.U., Spain;
1–2 ml SC). In particular, BM specimens were collected
from the iliac crest using Rosenthal needles (16 or 18
gauges) and 10 ml syringes and Giemsa-stained prior
to microscopical examination to evaluate cytological
changes.Cytological examination
A 500-cell differential count was performed on BM smears;
the myeloid to erythroid (M:E) ratio, myeloid maturation
index (MMI), erythroid maturation index (EMI) were
calculated. The maturation index was defined as the
ratio between the number of proliferative phase cells
and the number of maturation phase cells in the BM
(typically 1:4 in mammals [14]); the MMI is defined as
(myeloblasts + promyelocytes +myelocytes) ÷ (metamyelo-
cytes + bands + segmenters), while the EMI is defined as
(rubriblasts + prorubricytes) ÷ (rubricytes +metarubricytes)
[15]. Reference ranges used in this study for each cell
type and for the different ratios have been reported
elsewhere [16,17].
The mean number of megakaryocytes was determined
for each dog at low magnification (i.e. 10x); megakaryo-
cytic hyperplasia was defined as >3 cells/low-power field
[18]. The percentages of myeloid precursors, erythroid
cells, and megakaryocytes with dysplastic features were
determined. Dysplasia was defined as the occurrence of
dysplastic features in over 10% of the counted cells
[19,20]. The term ‘depletion’ of one or more BM cell
lineages was used for dogs with peripheral cytopenia and
BM within reference intervals or hypoplastic BM with a
normal or reduced maturation index. Conversely, ‘suppres-
sion’ was used to indicate dogs with peripheral cytopenia,
accompanied by BM hypoplasia and an increased matur-
ation index [21].Statistical analysis
The Fisher’s exact test was used to evaluate the differ-
ences in the percentages of abnormalities among dogs
with a single infection and between dogs with single in-
fection and those with co-infection. Data were organized
in several 2X2 contingency tables comparing, for each ab-
normality, dogs with a specific vector-borne disease with
dogs with another vector-borne disease or a co-infection
status, with the aim to reveal a significant higher
prevalence of a given abnormality in the two groups.
A publicly available online software was used (©2014
GraphPad Software, Inc. at: http://www.graphpad.com/
quickcalcs/contingency2/).
Table 2 Peripheral findings compared with BM pathologic changes (*)
Blood Bone marrow
Erythroid suppression, myeloid and or megakaryocyte dysplasia
Ap Hc Li Co-i Tot Ap Hc Li Co-i Tot
N/10 (%) N/33 (%) N/13 (%) N/27 (%) N/83 (%) N/10 (%) N/33 (%) N/13 (%) N/27 (%) N/83 (%)
Normal CBC 0 (0) 1 (3.0) 3 (23.1) 1 (3.7) 5 (6.0) 0 (0) 1 (3.0) 3 (23.1)a 0 (0)a 4 (4.8)
WBC increase in the differential count 2 (20) 14 (42.4) 1 (7.8) 6 (22.2) 23 (27.7) 2 (20) 12 (36.4)b 0 (0)b 4 (14.8) 18 (21.7)
Cytopenia Anemia 3 (30) 10 (30.3) 6 (46.2) 15 (55.5) 34 (41.0) 3 (30) 14 (42.4) 7 (53.8) 16 (59.2) 40 (48.2)
Thrombocytopenia 0 (0) 4 (12.1) 1 (7.8) 1 (3.7) 6 (7.2)
Bicytopenia Anemia/Thrombocytopenia 1 (10) 4 (12.1) 0 (0) 3 (11.1) 8 (9.6) 2 (20) 4 (12.1) 2 (15.4) 4 (14.8) 12 (14.4)
Anemia/Neutropenia 1 (10) 0 (0) 2 (15.4) 1 (3.7) 4 (4.8)
Pancytopenia 3 (30)Cd 0 (0)C 0 (0) 0 (0)d 3 (3.6) 3 (30)Ef 0 (0)E 0 (0) 0 (0)f 3 (3.6)
Total 10 (100) 30 (93.9) 12 (92.3) 24(88.92) 77 (92.8)
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CBC and BM findings are summarized in Tables 2, 3
and 4, respectively; the main dysplastic figures observed
in the BM samples are reported in Table 4 and Figure 1.
Most BM specimens did not display alterations in cellu-
larity; moreover, the blast cell count was <6% in all dogs,
therefore the occurrence of acute myeloproliferative dis-
orders, as a cytopathological differential diagnosis, was
excluded. Out of 83 dogs included in this study, only 5
(6%) had CBC counts within reference intervals, i.e. one
A. platys and H. canis co-infected dog with no blood or
BM abnormalities and one H. canis and three L. infantum
infected dogs showing BM myeloid and/or megakaryo-
cytic dysplasia, atypical mitosis and suppression of eryth-
roid and/or myeloid lineage.
Eighteen of 23 non-cytopenic dogs (27.7%) with white
blood cells count abnormalities including leukocytosis
(n = 12/23), neutrophilia (n = 6/23), eosinophilia (n = 20/23),
lymphocytosis (n = 15/23) and monocytosis (n = 7/23) were
characterized by dysplasia of the myeloid and/or megakaryo-
cytic lineages. Four out of the 23 non-cytopenic dogs had
myeloid ‘suppression’ and/or ‘depletion’ without evidence of
dysplasia.
Single and multiple cytopenia (Table 2) were identified
in 55 out of the 83 dogs enrolled in this study. Forty
dogs (48.2%) had a single peripheral cytopenia, of which
34 were anemic and 6 were thrombocytopenic. Three
dogs had depletion of all BM lineages in association
with severe lymphocytic hyperplasia; seven dogs dis-
played suppression of erythroid or myeloid lineage,




RBC Normal 2 (20) 19 (57
Anemia 8 (80) 14 (42
WBC Normal 2 (20) 4 (12.1
Leukocytosis 1 (10)b 19 (57
Leukopenia 1 (10) 0 (0)
Neutrophilia 1 (10) 10 (30
Neutropenia 4 (40)Eg 0 (0)E
Eosinophilia 3 (30)H 26 (78
Monocytosis 1 (10) 5 (15.2
Monocytopenia 0 (0) 1 (3.0)
Lymphocytosis 2 (20)l 21 (75
Lymphopenia 1 (10) 0 (0)
PLT Normal 6 (60) 25 (75
Reduced 4 (40)m 8 (24.2
(*) significant differences are marked by equal letters (lowercase = p < 0.05; uppercawere detected in the remaining 30 dogs. Twelve out of 83
dogs had peripheral bi-cytopenia, in association with BM
differential cell count abnormalities and typical features of
dysplasia. Lastly, three pancytopenic A. platys-infected
dogs, had BM changes consistent with both dysplastic fea-
tures and abnormalities in the differential count.
Discussion
In this study, dysmyelopoiesis characterized by the pres-
ence of BM dysgranulopoiesis and dysmegakaryocyto-
poiesis was observed in dogs infected by L. infantum, A.
platys and H. canis. Secondary dysmyelopoiesis, which is
a non-clonal condition, has generally been associated
with the administration of drugs such as estrogen and
chloramphenicol, toxin exposure and other specific disease
processes, including lead toxicity and iron deficiency [20].
Interestingly, in several instances, BM observations were
not in accordance with the corresponding cell counts in
peripheral blood, i.e. anemia vs erythroid hypoplasia,
normal WBC and PLT count vs marrow lymphocytosis,
monocytosis and megakaryocytic hyperplasia.
In addition, co-infection by two or more CVBD patho-
gens was associated with more severe BM disorders that
were notably different from the abnormalities in dogs in-
fected by a single pathogen.
Normocytic normochromic non-regenerative anemia
(NNNA), which was observed in this study (data not
shown), is a common finding in CVBDs, including leish-
maniasis [1,22], hepatozonoosis [23,24] and, to a lesser
extent, anaplasmosis [25]. Interestingly, our data indi-
cates an association between the erythroid hypoplasiaVBD pathogens (*)
Li Co-i Tot
(%) N/13 (%) N/27 (%) N/83 (%)
.6) 5 (38.5) 8 (29.6) 34 (41.0)
.4)a 8 (61.5) 19 (70.3)a 49 (59.0)
) 6 (46.1) 7 (25.9) 19 (22.9)
.6)bCd 1 (7.7)C 7 (25.9)d 28 (33.7)
2 (15.4) 0 (0) 3 (3.6)
.3) 1 (7.7) 9 (33.3) 21 (25.3)
2 (15.4) 1 (3.7)g 7 (8.4)
.8)HI 3 (23.0)I 14 (51.8) 46 (55.4)
) 1 (7.7) 5 (18.5) 12 (14.4)
0 (0) 0 (0) 1 (1.2)
.8)l 5 (38.5) 13 (48.1) 41 (49.4)
1 (7.7) 1 (3.7) 3 (3.6)
.8) 12 (92.3) 26 (96.3) 69 (83.1)
) 1 (7.7) 1 (3.7)m 14 (16.9)
se = p < 0.01).
Table 4 BM differential count and dysplastic changes in 83 dogs infected by different CVBD pathogens (*)
Bone marrow
Differential count Dysplasia
Ap Hc Li Co-i Tot Ap Hc Li Co-i Tot
BM lineage N/10 (%) N/33 (%) N/13 (%) N/27 (%) N/83 (%) Precursors Abnormalities N/10 (%) N/33 (%) N/13 (%) N/27 (%) N/83 (%)
Erythroid Normal 6 (60) 20 (60.6) 3 (23.0) 14 (51.8) 43 (51.8) -
Hyperplasia 1 (10) 9 (27.3) 2 (15.4) 7 (25.9) 19 (22.9) Promyelocytes Bilobated nuclei - - 1 (7.7) 1 (3.7) 2 (2.4)
Hypoplasia 3 (30) 4 (12.1)A 8 (61.5)Ab 6 (22.2)b 21 (25.3) Metamyelocytes Giants 2 (20) 10 (30.3) 3 (23.0) 6 (22.2) 21 (25.3)
EMI Normal 1 (10)c 15 (45.4) 2 (15.4) 14 (51.8)c 32 (38.5) Basophilia cytoplasm - 4 (12.1) 4 (30.8) 4 (14.8) 12 (14.4)
Increased 9 (90)D 18 (54.5) 9 (69.2) 10 (37)D 46 (55.4) Vacuolized cytoplasm - - 1 (7.7) 1 (3.7) 2 (2.4)
Reduced - - 2 (15.4) 3 (11.1) 5 (6) Banda Ring nuclei - 2 (6) 1 (7.7) - 3 (3.6)
Myeloid Normal 5 (50) 20 (60.6) 6 (46.1) 14 (51.8) 45 (54.2) Basophilia cytoplasm - 1 (3.0) - - 1 (1.2)
Hyperplasia 3 (30) 2 (6) 2 (15.4) 3 (11.1) 10 (12) Segmented Dohle bodies 3 (30) 6 (18.1) 2 (15.4) 4 (14.8) 15 (18)
Hypoplasia 2 (20) 11 (33.3) 5 (38.4) 10 (37) 27 (32.5) Hypersegmented 6 (60) 11 (33.3) 7 (53.8) 10 (37) 34 (41)
MMI Normal 2 (20) 16 (48.5) 8 (61.5) 12 (44.4) 38 (45.8) Basophilia cytoplasm 1 (10) - 1 (7.7) - 2 (2.4)
Increased 3 (30) 6 (18.1) 4 (30.8) 8 (29.6) 21 (25.3) Monocytes/ Macrophages Vacuolized cytoplasm 3 (30)O 0(0)Op 1 (7.7) 5 (18.5)p 9 (10.8)
Reduced 5 (50) 11 (33.3) 1 (7.7) 7 (25.9) 24 (28.9) Erythrophagocytosis 2 (20) 4 (12.1) - 5 (18.5) 11 (13.2)
Lymphocytic
hyperplasia
2 (20)e 10 (30.3)F 10 (76.9)eF 15 (55.5) 37 (44.6) Platelet phagocytosis 2 (20) - - 1 (3.7) 3 (3.6)
Plasma cells
hyperplasia
2 (20)g 15 (45.4) 9 (69.2)g 13 (48.1) 39 (47) Megakaryocytes Dwarfs 4 (40) 8 (24.2) 2 (15.4) 4 (14.8) 18 (21.7)
Monocytic
hyperplasia
9 (90)h 15 (45.4)h 8 (61.5) 17 (63) 49 (59) Hyperlobulated nuclei 3 (30) 4 (12.1) 2 (15.4) 2 (7.4) 11 (13.2)
Megakaryocytes Normal 2 (20) 10 (30.3) 4 (30.8) 7 (25.9) 23 (27.7) Hypolobulated nuclei - 6 (18.1) - 1 (3.7) 7 (8.4)
Hyperplasia 7 (70) 22 (66.6) 6 (46.1) 14 (51.8) 49 (59.0) Disorganized nuclei 7 (70)Qrs 7 (21.2)Q 3 (23.0)r 6 (22.2)s 23 (27.7)
Hypoplasia 1 (10) 1 (3.0)i 3 (23.0) 6 (22.2)i 11 (13.2) Fragmented cytoplasm 6 (60)TUv 2 (6)T 0(0)U 4 (14.8)v 12 (14.4)
Mitosis Normal 6 (60)l 17 (51.5)m 2 (15.3)lm 10 (37) 35 (42.1) Inclusions 2 (20) - - - 2 (2.4)
Increased 3 (30) 7 (21.2)n 8 (61.5)n 7 (25.9) 25 (30.1) Emperipolesis 5 (50)z 4 (12.1)zW 2 (15.4) 12 (44.4)W 33 (39.8)
Reduced 1 (10) 9 (27.3) 3 (23.0) 10 (37) 23 (27.7) Mitosis Atypical 0(0)X 2 (6)Y (61.5)XYβ 3 (11.1) β 10 (12)







































































































































































































Anaplasma platys Hepatozoon canis
Leishmania infantum Co-infections
Figure 1 Frequency of dysplastic figures of the bone marrow of 83 dogs naturally infected by different CVBD pathogens.
Figure 2 A megaloblastic erythroid precursor with multiple
nuclei (arrow); two other eryhtroid precursors are also present.
Bone marrow. Quick Stain, 100×.
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co-infected dogs (Group Co-i) and H. canis-infected
dogs. NNNA and erythroid hypoplasia with an increase
in EMI was associated to small numbers of L. infantum
parasites in BM samples, in contrast to a previous report
in which non-regenerative anemia had been associated
with large parasite numbers in the BM [9]. A non-
regenerative anemia was also observed in dogs infected
by A. platys and H. canis (group Ap and Hc, respect-
ively) and was associated with an increased EMI, in spite
of a reduced or even absent proliferation of erythroid
precursors (i.e. rubriblasts and prorubrocytes) in the BM
of infected animals. This may be due to the elicitation of
a humoral and/or cell-mediated immune response di-
rected against early erythroid precursors [19]. However,
further studies are necessary in order to elucidate the re-
lationship/s between infections by A. platys and H. canis
infection and suppression of erythropoiesis.
Erythroid hyperplasia and mild dyserythropoiesis char-
acterized by megaloblastic erythroid cells with multiple
nuclei (Figure 2) were observed in two dogs <8 months
of age. These morphologic abnormalities are most often
seen in animals with myeloproliferative disorders, con-
genital dyserythropoiesis or following treatment with
chemotherapeutic drugs [26]. It was unclear whether the
changes observed in the BM of the two young animals
were associated to an evolving myelodysplastic syn-
drome not yet manifested.
Eosinophilia was observed in 55.4% of the dogs and
more frequently in H. canis-infected dogs. Examination of
BM smears from these dogs revealed myeloid cells withinreference intervals or myeloid hypoplasia in association with
an increased BM eosinophilic component (data not shown).
Peripheral eosinophilia has already been linked to H. canis
[24,27] and canine Bartonella infections [28,29]; however, it
is important to note that this condition may also be caused
by a number of diseases other than CVBDs [30], as well as
by concomitant infections by gastrointestinal parasites which
were not investigated in dogs included in this study.
Leukocytosis was often observed in H. canis infected
dogs (group Hc); interestingly, neutrophilia, which is usu-
ally associated with high rates of parasitemia [24], was not
recorded in this study, possibly as a consequence of the
small numbers of parasitized neutrophils (data not shown).
Figure 3 Myeloid dysplasia. A. A hypersegmented mature neutrophil (arrow); myeloid precursors in different maturation stages are also present.
B. A giant metamyelocyte (arrow) with two erythroid precursors. Bone marrow. Quick Stain, 100×.
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eral WBC counts or with neutrophilia was observed in 11
(33.3%) H. canis-infected dogs and in 10 (37%) H. canis -
L. infantum co-infected dogs. This finding is not easily
explained as granulocytic hypoplasia is generally asso-
ciated with peripheral neutropenia. The BM of these
animals was considered suppressed due to an absence
of proliferation (MMI increased). It is possible that the
mature neutrophilia in peripheral blood with simultan-
eous suppression of the myelocytic cell lines may be due
to other factors such as mobilization and demargination
of neutrophils due to stress and excitement [31].
Dysmorphic changes in neutrophilic granulocytes, which
generally occurs in animals with inflammatory diseases
and/or dysgranulopoiesis [32,33] were observed, with vary-
ing prevalence (Table 4, Figures 3B, 1). Therefore, vector-
borne pathogens, and in particular H. canis, should beFigure 4 Platelets and erythrophagocytosis. A. A macrophage phagocyt
debris. B. Two macrophages with the same features described in A. Bone maconsidered among the secondary causes of dysgranulopoi-
esis in dogs. Indeed, morphological abnormalities were
also observed in peripheral neutrophils (data not shown,
Figure 3A) of dogs infected by H. canis (group Hc) and in
H. canis co-infected dogs (Group Co-i).
Severe BM lymphocytosis, plasma cell hyperplasia and/
or monocytosis were frequently observed in dogs infected
with A. platys, L. infantum and H. canis. This may be re-
lated to chronic antigenic stimulation as it has been
shown for other CVBDs, such as canine monocytic ehr-
lichiosis [34]. Interestingly, these BM changes were not
reflected in CBCs, since most dogs had peripheral blood
lymphocytes and monocytes within reference intervals.
Hemophagocytic macrophages containing erythrocytes
were observed in the BM of A. platys and H. canis in-
fected dogs, whereas these cells were not detected in
BM samples from L. infantum infected dogs, in contrasting erythroid precursors (red arrow), platelets (black arrow) and cellular
rrow. Quick Stain, 100×.
Figure 5 Megakaryocytic dysplasia. A. Megakaryocytic precursor with four divided nuclei. B. A megakaryocyte presenting morphologic
abnormalities in nucleus shape and emperipolesis (arrow). Bone marrow. Quick Stain, 100×.
Figure 6 Atypical mitosis. Bone marrow. Quick Stain, 100×.
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immune-mediated, due to antibody or possibly com-
plement deposition on the surface of red cells, as it has
been described for several vector-borne diseases [8]. It
is also possible that infection-induced red cell abnor-
malities may alter membrane properties that result in
reduced red cell lifespan and trigger phagocytosis [33].
Erythrophagocytosis may also occur as an “innocent
bystander effect” whereby phagocytic macrophages re-
move red cells in the process of removing cellular deb-
ris, such as in the case of disseminated fungal infection
[35], lymphocytic leukemia, myelomonocytic leukemia
[36] and BM necrosis [37]. Erythrophagocytosis and
platelet phagocytosis were observed in four A. platys
infected dogs (Figure 4A,B), consistent with the immune-
mediated thrombocytopenia that this pathogen is known
to induce [38,39].
Megakaryocytic hyperplasia and dysplasia were the
most frequent BM findings in this study. They were ob-
served in all CVBD infection groups and they were espe-
cially frequent in A. platys infected dogs. Despite the
presence of these abnormalities in the BM, numbers of
platelets in peripheral blood were frequently normal.
Features of megakaryocytic dysplasia included asynchron-
ous maturation resulting in dwarf granular megakaryo-
cytes, hyperlobulated, hypolobulated and/or disorganized
nuclei (Figure 5A,B) and cytoplasmic abnormalities
(tattered fringe and inclusions). We hypothesize an immune-
mediated cause for the megakaryocytic dysplasia observed,
in accordance with previous reports of dogs infected
by L. infantum [8].
Emperipolesis (Figure 5B), i.e. engulfing of various BM
cells by megakaryocytes [40], was also frequently observed
in this study. Emperipolesis increases in various disorders,
including multiple myeloma, carcinoma, lymphoma [41],
platelet disorders [42] and serious hemorrhage [43], how-
ever the pathophysiological importance of emperipolesisis
is yet to be fully understood and its significance is uncer-
tain [44,45]. Indeed, this event may be linked to the effects
of interleukin-6 (IL-6), which alters the process of mega-
karyocyte maturation, thus altering thrombocytopoiesis[45]. To our knowledge, prior to the present study,
emperipolesis had only been described in dogs infected
by L. infantum [8] and A. platys [39]; we describe, for
the first time, emperipolesis in dogs infected or co-infected
by H. canis. Lastly, atypical mitotic figures were noted
infrequently in dogs infected or co-infected by H. canis
and L. infantum (Figure 6), thus raising the question of
whether selected CVBDs may indeed represent previously
unrecognized causes of secondary dysmyelopoiesis.
Conclusions
This study provides information on the cytological disor-
ders and pathological changes occurring in the BM of
dogs naturally infected by a range of CVBD-causing
pathogens. Dysgranulopoiesis and dysmegakaryocytopoi-
esis (i.e. emperipolesis) were typical BM alterations associ-
ated with H. canis infections. Megakaryocytic hyperplasia
and dysplasia were observed in A. platys infected dogs,
even in absence of thrombocytopenia at the time of test-
ing, whilst infection with L. infantum was linked to BM
erythroid suppression, infiltration of the BM with lympho-
cytes and plasma cells and the presence of atypical mitosis.
Finally, more severe BM disorders were observed in dogs
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http://www.parasitesandvectors.com/content/7/1/534co-infected by two or more CVBD pathogens than in dogs
infected by a single agent. Based on our findings, infec-
tions by vector-borne pathogens should be considered
as differential diagnoses for secondary myelodysplasia
in dogs. Additional studies that further describe and
explore mechanisms of BM changes induced by these
agents and their relationship with observed changes in
peripheral blood cell counts during the course of infec-
tion appear warranted.
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